Want to join the conversation?
Biotechnology company $GILD said that it it has submitted a New Drug Application (NDA) to the FDA for tenofovir alafenamide (TAF) 25 mg, a once-daily drug for treating adults with chronic hepatitis B virus (HBV) infection, a condition of the liver. $GILD plans to submit a regulatory application for TAF in the EU in the 1Q16.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!